Antioxidant treatment for heart failure: friend or foe?
Authors:
Open Access
- 17 December 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 102 (5) , 305-310
Abstract
Increasing studies demonstrate a pivotal role for oxidant stress in the pathophysiology of heart failure (HF). Recent meta-analyses also reveal the potential pitfall of a mono-dimensional antioxidant approach. This review article summarizes the main biological pathways involved in oxidant stress and HF, the possible deleterious nature of certain antioxidant monotherapy and proposes potential antioxidant strategies necessary to challenge specific HF aetiology and progression.Keywords
This publication has 56 references indexed in Scilit:
- Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart ratsJournal of Molecular and Cellular Cardiology, 2007
- Myocardial Glucose Transport and Utilization in Patients With Type 2 Diabetes Mellitus, Left Ventricular Dysfunction, and Coronary Artery DiseaseJACC, 2006
- NADPH oxidase and heart failureCurrent Opinion in Pharmacology, 2006
- Nitrosative stress and pharmacological modulation of heart failureTrends in Pharmacological Sciences, 2005
- Comparison of Prognostic Value of Negative Dobutamine Stress Echocardiography Versus Single-Photon Emission Computed Tomography After Acute Myocardial InfarctionThe American Journal of Cardiology, 2005
- Influence of Vitamin C on Baroreflex Sensitivity in Chronic Heart FailureHypertension, 2003
- Role of nitric oxide and oxidative stress in baroreceptor dysfunction in patients with chronic heart failureClinical Science, 2003
- Is the Emperor Wearing Clothes?Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Dietary Supplementation With n-3 Polyunsaturated Fatty Acids and Vitamin E After Myocardial Infarction: Results of the Gissi-Prevenzione TrialJournal of Cardiopulmonary Rehabilitation, 2000
- Multiple mitochondrial DNA deletions exist in cardiomyocytes of patients with hypertrophic or dilated cardiomyopathyBiochemical and Biophysical Research Communications, 1990